GM BULLETIN
GM Bulletin is our twice-monthly e-alert bringing you the latest
information on GM and GM2, news on the latest policy, research, and
guidelines. Subscribe by emailing
GMnews@oceanmedia.co.uk
BULLETIN
Dear GM
Reader
Welcome to the new GM Journal Bulletin. Each month we will link you
to the latest edition of GM online as well as the latest news and
views affecting healthcare professionals with an interest in the 50
years plus patient.
As well as online access to the journal, you can obtain a digital
version of GM by clicking here. Tablet users can also register to
experience GM interactively.
On Thursday
October 11th, the GM conference
The Ageing Patient: today and
tomorrow will take
place at the Wellcome Conference Centre, Euston Road, London. To
register your interest and further details on the agenda and prices
please go to
www.gerimed.co.uk/conference
or call 0207 772
8467.
GM
This month's GM has a wide
range of articles from Tinnitus to
Angina.
Articles are available
online
now. You can also access
our
digital edition
.
In this month's GM:
·
Commentary
Should doctors strike?
·
Opinion
The NSF for Older People
·
Pain
Chronic pain in older people
·
Psychiatry
Charles Bonnet Syndrome
·
Neurology
Restless legs syndrome
·
Cardiology
Angina
·
Otology
Tinnitus
News
National Audit of
Dementia
The first full report of the National Audit of
Dementia has identified a need for significant improvements in
hospital ward environments, staff training and the overall approach
to care delivery for patients with dementia.
New drug for C.
difficile
The European Commission has granted a marketing
authorisation for fidaxomicin (DIFICLIR™) tablets for the treatment
of adults with Clostridium difficile infections (CDI), also known as
C. difficile-associated diarrhoea (CDAD), in the European
Union.
Wales patients to receive
Dupuytren's contracture treatment
NHS patients in Wales will now have access to the
first licensed injectable treatment option for Dupuytren's
contracture, which has been recommend for restricted use by All Wales
Medicine Strategy Group (AWMSG).
Collagenase clostridium histolyticum (Xiapex®) was
launched in the UK in April 2011, to treat Dupuytren's
contracture in adult patients with a palpable cord. Collagenase
clostridium histolyticum offers an alternative treatment option to
surgery for Dupuytren's contracture.
New AF registry
The first patient has been enrolled into the
PREvention oF thromboembolic events - European Registry in Atrial
Fibrillation (PREFER in AF). Taking a comprehensive approach to the
patient registry, PREFER in AF will gather data on the full spectrum
of AF patients including those with valvular and non valvular forms
of the condition.
NICE criticised for
prostate drug
The Prostate Cancer Charity has criticised NICE for
not recommending the newly licensed chemotherapy drug cabazitaxel as
a treatment for men with advanced prostate cancer despite evidence
the drug significantly extends the lives of men in the advanced
stages of the disease.
A new vision for old
age
In a new study from the Economist Intelligence Unit
on healthcare provision for an ageing population, supported by
Pfizer, the overwhelming majority of health professionals surveyed
(80%) express their concern about how they will be treated when they
grow old. They are sceptical that current policies to address
demographic shift caused by an ageing population are comprehensive,
realistic or sufficiently funded to address future demand.
** GM is not responsible for external sites
To unsubscribe, reply with "unsubscribe"
in the subject line.